Chronic kidney disease (CKD) is a condition characterized by a gradual loss of renal function over time. To learn more about kidney function, see how your kidneys work. CKD is also known as chronic kidney disease.The Chronic Kidney Disease (CKD) Drug market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Chronic Kidney Disease (CKD) Drug industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Chronic Kidney Disease (CKD) Drug market can be split based on product types, major applications, and important countries as follows:
Key players in the global Chronic Kidney Disease (CKD) Drug market covered in Chapter 12:
FibroGen
Vifor Pharma Ltd
AMAG Pharmaceuticals
Keryx Biopharmaceuticals
Pharmacosmos
Johnson & Johnson
Amgen Inc.
Regulus Therapeutics
Actavis PLC
Rockwell Medical
Cara Therapeutics
Reata Pharmaceuticals
Raptor Pharmaceuticals
Akebia Therapeutics
Sanofi
Takeda Pharmaceuticals
OPKO Health
ZS Pharma
F. Hoffmann-La Roche Ltd
Shield Therapeutics
Abbott Laboratories
Xenetic Biosciences
In Chapter 4 and 14.1, on the basis of types, the Chronic Kidney Disease (CKD) Drug market from 2015 to 2025 is primarily split into:
ACE Inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers
Erythropoiesis-stimulating agents (ESAs)
Diuretics
Others
In Chapter 5 and 14.2, on the basis of applications, the Chronic Kidney Disease (CKD) Drug market from 2015 to 2025 covers:
Hospitals
Specialty Clinics
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
COVID-19 Outbreak-Global Chronic Kidney Disease (CKD) Drug Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Table of Content
1 Chronic Kidney Disease (CKD) Drug Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Chronic Kidney Disease (CKD) Drug
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Chronic Kidney Disease (CKD) Drug industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Chronic Kidney Disease (CKD) Drug Market Size, 2015 - 2020
2.1.2 Global Chronic Kidney Disease (CKD) Drug Market Size by Type, 2015 - 2020
2.1.3 Global Chronic Kidney Disease (CKD) Drug Market Size by Application, 2015 - 2020
2.1.4 Global Chronic Kidney Disease (CKD) Drug Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Chronic Kidney Disease (CKD) Drug Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Chronic Kidney Disease (CKD) Drug Analysis
3.2 Major Players of Chronic Kidney Disease (CKD) Drug
3.3 Chronic Kidney Disease (CKD) Drug Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Chronic Kidney Disease (CKD) Drug
3.3.3 Labor Cost of Chronic Kidney Disease (CKD) Drug
3.4 Market Distributors of Chronic Kidney Disease (CKD) Drug
3.5 Major Downstream Buyers of Chronic Kidney Disease (CKD) Drug Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Chronic Kidney Disease (CKD) Drug Market, by Type
4.1 Global Chronic Kidney Disease (CKD) Drug Value and Market Share by Type (2015-2020)
4.2 Global Chronic Kidney Disease (CKD) Drug Production and Market Share by Type (2015-2020)
4.3 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate by Type (2015-2020)
4.3.1 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of ACE Inhibitors
4.3.2 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of Angiotensin-II receptor blockers
4.3.3 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of Calcium channel blockers
4.3.4 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of Beta blockers
4.3.5 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of Erythropoiesis-stimulating agents (ESAs)
4.3.6 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of Diuretics
4.3.7 Global Chronic Kidney Disease (CKD) Drug Value and Growth Rate of Others
4.4 Global Chronic Kidney Disease (CKD) Drug Price Analysis by Type (2015-2020)
5 Chronic Kidney Disease (CKD) Drug Market, by Application
5.1 Downstream Market Overview
5.2 Global Chronic Kidney Disease (CKD) Drug Consumption and Market Share by Application (2015-2020)
5.3 Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate of Hospitals (2015-2020)
5.3.2 Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate of Specialty Clinics (2015-2020)
6 Global Chronic Kidney Disease (CKD) Drug Market Analysis by Regions
6.1 Global Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Regions
6.1.1 Global Chronic Kidney Disease (CKD) Drug Sales by Regions (2015-2020)
6.1.2 Global Chronic Kidney Disease (CKD) Drug Revenue by Regions (2015-2020)
6.2 North America Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
6.3 Europe Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
6.6 South America Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
7 North America Chronic Kidney Disease (CKD) Drug Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Countries
7.2.1 North America Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
7.2.2 North America Chronic Kidney Disease (CKD) Drug Revenue by Countries (2015-2020)
7.3 United States Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
7.4 Canada Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
7.5 Mexico Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
8 Europe Chronic Kidney Disease (CKD) Drug Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Countries
8.2.1 Europe Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
8.2.2 Europe Chronic Kidney Disease (CKD) Drug Revenue by Countries (2015-2020)
8.3 Germany Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
8.4 UK Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
8.5 France Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
8.6 Italy Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
8.7 Spain Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
8.8 Russia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
9 Asia Pacific Chronic Kidney Disease (CKD) Drug Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
9.2.2 Asia Pacific Chronic Kidney Disease (CKD) Drug Revenue by Countries (2015-2020)
9.3 China Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
9.4 Japan Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
9.5 South Korea Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
9.6 India Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
9.8 Australia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
10 Middle East and Africa Chronic Kidney Disease (CKD) Drug Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Chronic Kidney Disease (CKD) Drug Revenue by Countries (2015-2020)
10.3 Saudi Arabia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
10.4 UAE Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
10.5 Egypt Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
10.6 Nigeria Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
10.7 South Africa Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
11 South America Chronic Kidney Disease (CKD) Drug Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Chronic Kidney Disease (CKD) Drug Sales, Revenue and Market Share by Countries
11.2.1 South America Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
11.2.2 South America Chronic Kidney Disease (CKD) Drug Revenue by Countries (2015-2020)
11.3 Brazil Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
11.4 Argentina Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
11.5 Columbia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
11.6 Chile Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 FibroGen
12.1.1 FibroGen Basic Information
12.1.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.1.3 FibroGen Production, Value, Price, Gross Margin 2015-2020
12.2 Vifor Pharma Ltd
12.2.1 Vifor Pharma Ltd Basic Information
12.2.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.2.3 Vifor Pharma Ltd Production, Value, Price, Gross Margin 2015-2020
12.3 AMAG Pharmaceuticals
12.3.1 AMAG Pharmaceuticals Basic Information
12.3.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.3.3 AMAG Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.4 Keryx Biopharmaceuticals
12.4.1 Keryx Biopharmaceuticals Basic Information
12.4.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.4.3 Keryx Biopharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.5 Pharmacosmos
12.5.1 Pharmacosmos Basic Information
12.5.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.5.3 Pharmacosmos Production, Value, Price, Gross Margin 2015-2020
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Basic Information
12.6.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.6.3 Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
12.7 Amgen Inc.
12.7.1 Amgen Inc. Basic Information
12.7.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.7.3 Amgen Inc. Production, Value, Price, Gross Margin 2015-2020
12.8 Regulus Therapeutics
12.8.1 Regulus Therapeutics Basic Information
12.8.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.8.3 Regulus Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.9 Actavis PLC
12.9.1 Actavis PLC Basic Information
12.9.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.9.3 Actavis PLC Production, Value, Price, Gross Margin 2015-2020
12.10 Rockwell Medical
12.10.1 Rockwell Medical Basic Information
12.10.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.10.3 Rockwell Medical Production, Value, Price, Gross Margin 2015-2020
12.11 Cara Therapeutics
12.11.1 Cara Therapeutics Basic Information
12.11.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.11.3 Cara Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.12 Reata Pharmaceuticals
12.12.1 Reata Pharmaceuticals Basic Information
12.12.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.12.3 Reata Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.13 Raptor Pharmaceuticals
12.13.1 Raptor Pharmaceuticals Basic Information
12.13.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.13.3 Raptor Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.14 Akebia Therapeutics
12.14.1 Akebia Therapeutics Basic Information
12.14.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.14.3 Akebia Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.15 Sanofi
12.15.1 Sanofi Basic Information
12.15.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.15.3 Sanofi Production, Value, Price, Gross Margin 2015-2020
12.16 Takeda Pharmaceuticals
12.16.1 Takeda Pharmaceuticals Basic Information
12.16.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.16.3 Takeda Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.17 OPKO Health
12.17.1 OPKO Health Basic Information
12.17.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.17.3 OPKO Health Production, Value, Price, Gross Margin 2015-2020
12.18 ZS Pharma
12.18.1 ZS Pharma Basic Information
12.18.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.18.3 ZS Pharma Production, Value, Price, Gross Margin 2015-2020
12.19 F. Hoffmann-La Roche Ltd
12.19.1 F. Hoffmann-La Roche Ltd Basic Information
12.19.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.19.3 F. Hoffmann-La Roche Ltd Production, Value, Price, Gross Margin 2015-2020
12.20 Shield Therapeutics
12.20.1 Shield Therapeutics Basic Information
12.20.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.20.3 Shield Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.21 Abbott Laboratories
12.21.1 Abbott Laboratories Basic Information
12.21.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.21.3 Abbott Laboratories Production, Value, Price, Gross Margin 2015-2020
12.22 Xenetic Biosciences
12.22.1 Xenetic Biosciences Basic Information
12.22.2 Chronic Kidney Disease (CKD) Drug Product Introduction
12.22.3 Xenetic Biosciences Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Chronic Kidney Disease (CKD) Drug Market Forecast
14.1 Global Chronic Kidney Disease (CKD) Drug Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 ACE Inhibitors Market Value and Volume Forecast (2020-2025)
14.1.2 Angiotensin-II receptor blockers Market Value and Volume Forecast (2020-2025)
14.1.3 Calcium channel blockers Market Value and Volume Forecast (2020-2025)
14.1.4 Beta blockers Market Value and Volume Forecast (2020-2025)
14.1.5 Erythropoiesis-stimulating agents (ESAs) Market Value and Volume Forecast (2020-2025)
14.1.6 Diuretics Market Value and Volume Forecast (2020-2025)
14.1.7 Others Market Value and Volume Forecast (2020-2025)
14.2 Global Chronic Kidney Disease (CKD) Drug Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Hospitals Market Value and Volume Forecast (2020-2025)
14.2.2 Specialty Clinics Market Value and Volume Forecast (2020-2025)
14.3 Chronic Kidney Disease (CKD) Drug Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter's Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
?
List of Tables and Figures
Figure Product Picture of Chronic Kidney Disease (CKD) Drug
Table Product Specification of Chronic Kidney Disease (CKD) Drug
Table Chronic Kidney Disease (CKD) Drug Key Market Segments
Table Key Players Chronic Kidney Disease (CKD) Drug Covered
Figure Global Chronic Kidney Disease (CKD) Drug Market Size, 2015 - 2025
Table Different Types of Chronic Kidney Disease (CKD) Drug
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) Segment by Type from 2015-2020
Figure Global Chronic Kidney Disease (CKD) Drug Market Share by Types in 2019
Table Different Applications of Chronic Kidney Disease (CKD) Drug
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) Segment by Applications from 2015-2020
Figure Global Chronic Kidney Disease (CKD) Drug Market Share by Applications in 2019
Figure Global Chronic Kidney Disease (CKD) Drug Market Share by Regions in 2019
Figure North America Chronic Kidney Disease (CKD) Drug Production Value ($) and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drug Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific Chronic Kidney Disease (CKD) Drug Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drug Production Value ($) and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drug Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of Chronic Kidney Disease (CKD) Drug
Table Upstream Raw Material Suppliers of Chronic Kidney Disease (CKD) Drug with Contact Information
Table Major Players Headquarters, and Service Area of Chronic Kidney Disease (CKD) Drug
Figure Major Players Production Value Market Share of Chronic Kidney Disease (CKD) Drug in 2019
Table Major Players Chronic Kidney Disease (CKD) Drug Product Types in 2019
Figure Production Process of Chronic Kidney Disease (CKD) Drug
Figure Manufacturing Cost Structure of Chronic Kidney Disease (CKD) Drug
Figure Channel Status of Chronic Kidney Disease (CKD) Drug
Table Major Distributors of Chronic Kidney Disease (CKD) Drug with Contact Information
Table Major Downstream Buyers of Chronic Kidney Disease (CKD) Drug with Contact Information
Table Global Chronic Kidney Disease (CKD) Drug Value ($) by Type (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Value Share by Type (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value Share by Type (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Production by Type (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Production Share by Type (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Production Share by Type (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of ACE Inhibitors (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of Angiotensin-II receptor blockers (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of Calcium channel blockers (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of Beta blockers (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of Erythropoiesis-stimulating agents (ESAs) (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of Diuretics (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Value ($) and Growth Rate of Others (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global Chronic Kidney Disease (CKD) Drug Consumption by Application (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Consumption Market Share by Application (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Consumption Market Share by Application (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate of Hospitals (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Consumption and Growth Rate of Specialty Clinics (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Global Chronic Kidney Disease (CKD) Drug Revenue (M USD) and Growth (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Sales by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Sales Market Share by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue (M USD) by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue Market Share by Regions (2015-2020)
Table Global Chronic Kidney Disease (CKD) Drug Revenue Market Share by Regions in 2015
Table Global Chronic Kidney Disease (CKD) Drug Revenue Market Share by Regions in 2019
Figure North America Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Europe Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America Chronic Kidney Disease (CKD) Drug Revenue (M USD) and Growth (2015-2020)
Table North America Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
Table North America Chronic Kidney Disease (CKD) Drug Sales Market Share by Countries (2015-2020)
Table North America Chronic Kidney Disease (CKD) Drug Revenue (M USD) by Countries (2015-2020)
Table North America Chronic Kidney Disease (CKD) Drug Revenue Market Share by Countries (2015-2020)
Figure United States Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Canada Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Mexico Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe Chronic Kidney Disease (CKD) Drug Revenue (M USD) and Growth (2015-2020)
Table Europe Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
Table Europe Chronic Kidney Disease (CKD) Drug Sales Market Share by Countries (2015-2020)
Table Europe Chronic Kidney Disease (CKD) Drug Revenue (M USD) by Countries (2015-2020)
Table Europe Chronic Kidney Disease (CKD) Drug Revenue Market Share by Countries (2015-2020)
Figure Germany Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure UK Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure France Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Italy Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Spain Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Russia Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific Chronic Kidney Disease (CKD) Drug Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
Table Asia Pacific Chronic Kidney Disease (CKD) Drug Sales Market Share by Countries (2015-2020)
Table Asia Pacific Chronic Kidney Disease (CKD) Drug Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific Chronic Kidney Disease (CKD) Drug Revenue Market Share by Countries (2015-2020)
Figure China Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Japan Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure South Korea Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure India Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Southeast Asia Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Australia Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Middle East Chronic Kidney Disease (CKD) Drug Revenue (M USD) and Growth (2015-2020)
Table Middle East Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
Table Middle East and Africa Chronic Kidney Disease (CKD) Drug Sales Market Share by Countries (2015-2020)
Table Middle East and Africa Chronic Kidney Disease (CKD) Drug Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa Chronic Kidney Disease (CKD) Drug Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure UAE Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Egypt Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Nigeria Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure South Africa Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure South America Chronic Kidney Disease (CKD) Drug Revenue (M USD) and Growth (2015-2020)
Table South America Chronic Kidney Disease (CKD) Drug Sales by Countries (2015-2020)
Table South America Chronic Kidney Disease (CKD) Drug Sales Market Share by Countries (2015-2020)
Table South America Chronic Kidney Disease (CKD) Drug Revenue (M USD) by Countries (2015-2020)
Table South America Chronic Kidney Disease (CKD) Drug Revenue Market Share by Countries (2015-2020)
Figure Brazil Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Argentina Chronic Kidney Disease (CKD) Drug Sales and Growth Rate (2015-2020)
Figure Columbia Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Chile Chronic Kidney Disease (CKD) Drug Sales and Growth (2015-2020)
Figure Top 3 Market Share of Chronic Kidney Disease (CKD) Drug Companies in 2019
Figure Top 6 Market Share of Chronic Kidney Disease (CKD) Drug Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table FibroGen Profile
Table FibroGen Product Introduction
Figure FibroGen Production and Growth Rate
Figure FibroGen Value ($) Market Share 2015-2020
Table Vifor Pharma Ltd Profile
Table Vifor Pharma Ltd Product Introduction
Figure Vifor Pharma Ltd Production and Growth Rate
Figure Vifor Pharma Ltd Value ($) Market Share 2015-2020
Table AMAG Pharmaceuticals Profile
Table AMAG Pharmaceuticals Product Introduction
Figure AMAG Pharmaceuticals Production and Growth Rate
Figure AMAG Pharmaceuticals Value ($) Market Share 2015-2020
Table Keryx Biopharmaceuticals Profile
Table Keryx Biopharmaceuticals Product Introduction
Figure Keryx Biopharmaceuticals Production and Growth Rate
Figure Keryx Biopharmaceuticals Value ($) Market Share 2015-2020
Table Pharmacosmos Profile
Table Pharmacosmos Product Introduction
Figure Pharmacosmos Production and Growth Rate
Figure Pharmacosmos Value ($) Market Share 2015-2020
Table Johnson & Johnson Profile
Table Johnson & Johnson Product Introduction
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Amgen Inc. Profile
Table Amgen Inc. Product Introduction
Figure Amgen Inc. Production and Growth Rate
Figure Amgen Inc. Value ($) Market Share 2015-2020
Table Regulus Therapeutics Profile
Table Regulus Therapeutics Product Introduction
Figure Regulus Therapeutics Production and Growth Rate
Figure Regulus Therapeutics Value ($) Market Share 2015-2020
Table Actavis PLC Profile
Table Actavis PLC Product Introduction
Figure Actavis PLC Production and Growth Rate
Figure Actavis PLC Value ($) Market Share 2015-2020
Table Rockwell Medical Profile
Table Rockwell Medical Product Introduction
Figure Rockwell Medical Production and Growth Rate
Figure Rockwell Medical Value ($) Market Share 2015-2020
Table Cara Therapeutics Profile
Table Cara Therapeutics Product Introduction
Figure Cara Therapeutics Production and Growth Rate
Figure Cara Therapeutics Value ($) Market Share 2015-2020
Table Reata Pharmaceuticals Profile
Table Reata Pharmaceuticals Product Introduction
Figure Reata Pharmaceuticals Production and Growth Rate
Figure Reata Pharmaceuticals Value ($) Market Share 2015-2020
Table Raptor Pharmaceuticals Profile
Table Raptor Pharmaceuticals Product Introduction
Figure Raptor Pharmaceuticals Production and Growth Rate
Figure Raptor Pharmaceuticals Value ($) Market Share 2015-2020
Table Akebia Therapeutics Profile
Table Akebia Therapeutics Product Introduction
Figure Akebia Therapeutics Production and Growth Rate
Figure Akebia Therapeutics Value ($) Market Share 2015-2020
Table Sanofi Profile
Table Sanofi Product Introduction
Figure Sanofi Production and Growth Rate
Figure Sanofi Value ($) Market Share 2015-2020
Table Takeda Pharmaceuticals Profile
Table Takeda Pharmaceuticals Product Introduction
Figure Takeda Pharmaceuticals Production and Growth Rate
Figure Takeda Pharmaceuticals Value ($) Market Share 2015-2020
Table OPKO Health Profile
Table OPKO Health Product Introduction
Figure OPKO Health Production and Growth Rate
Figure OPKO Health Value ($) Market Share 2015-2020
Table ZS Pharma Profile
Table ZS Pharma Product Introduction
Figure ZS Pharma Production and Growth Rate
Figure ZS Pharma Value ($) Market Share 2015-2020
Table F. Hoffmann-La Roche Ltd Profile
Table F. Hoffmann-La Roche Ltd Product Introduction
Figure F. Hoffmann-La Roche Ltd Production and Growth Rate
Figure F. Hoffmann-La Roche Ltd Value ($) Market Share 2015-2020
Table Shield Therapeutics Profile
Table Shield Therapeutics Product Introduction
Figure Shield Therapeutics Production and Growth Rate
Figure Shield Therapeutics Value ($) Market Share 2015-2020
Table Abbott Laboratories Profile
Table Abbott Laboratories Product Introduction
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Value ($) Market Share 2015-2020
Table Xenetic Biosciences Profile
Table Xenetic Biosciences Product Introduction
Figure Xenetic Biosciences Production and Growth Rate
Figure Xenetic Biosciences Value ($) Market Share 2015-2020
Table Market Driving Factors of Chronic Kidney Disease (CKD) Drug
Table Merger, Acquisition and New Investment
Table Global Chronic Kidney Disease (CKD) Drug Market Value ($) Forecast, by Type
Table Global Chronic Kidney Disease (CKD) Drug Market Volume Forecast, by Type
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of ACE Inhibitors (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of ACE Inhibitors (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of Angiotensin-II receptor blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of Angiotensin-II receptor blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of Calcium channel blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of Calcium channel blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of Beta blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of Beta blockers (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of Erythropoiesis-stimulating agents (ESAs) (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of Erythropoiesis-stimulating agents (ESAs) (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of Diuretics (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global Chronic Kidney Disease (CKD) Drug Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Hospitals (2020-2025)
Figure Market Volume and Growth Rate Forecast of Hospitals (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Specialty Clinics (2020-2025)
Figure Market Volume and Growth Rate Forecast of Specialty Clinics (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter's Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Global Antioxidant Vitamins Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 100
The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
Global Clavulanate Potassium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030.
North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
Global Amoxicillin Sodium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 84
The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030.
North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
Global Melatonin Supplements Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 93
The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
Global Sleeping Pills Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Zinc Oral Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
Global Zinc Drops Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
Global Anti-Infectives Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
